Picture of Ipca Laboratories logo

IPCALAB Ipca Laboratories Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line13,81311,3577,4538,42711,311
Depreciation
Non-Cash Items-184-373-2641,3263,301
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4,819-4,707-1,747-3,114-5,377
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities10,9018,6028,05810,21213,213
Capital Expenditures-3,616-4,790-4,945-4,113-7,756
Purchase of Fixed Assets
Other Investing Cash Flow Items-1,591-3,761-2,305-8,805-939
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-5,207-8,551-7,250-12,918-8,695
Financing Cash Flow Items-84.1-61.8-415-1,343-744
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,0584,2685,072-5,526-2,830
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash2,6364,3195,881-8,2321,688